(NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 4.85% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.61%.
Qiagen Nv's revenue in 2025 is $2,070,781,000.On average, 25 Wall Street analysts forecast QGEN's revenue for 2025 to be $461,274,515,000, with the lowest QGEN revenue forecast at $434,281,575,000, and the highest QGEN revenue forecast at $479,995,425,000. On average, 25 Wall Street analysts forecast QGEN's revenue for 2026 to be $489,573,565,000, with the lowest QGEN revenue forecast at $460,403,775,000, and the highest QGEN revenue forecast at $514,607,340,000.
In 2027, QGEN is forecast to generate $520,049,465,000 in revenue, with the lowest revenue forecast at $485,655,235,000 and the highest revenue forecast at $551,396,105,000.